Stock Screener
Stock Research
Delisted Stocks
Market Indexes
Precious Metals
Energy
Commodities
Interest Rates
Economy
Global Metrics

Bristol Myers Squibb Total Assets 2010-2023 | BMY

Bristol Myers Squibb total assets from 2010 to 2023. Total assets can be defined as the sum of all assets on a company's balance sheet.
  • Bristol Myers Squibb total assets for the quarter ending June 30, 2023 were $93.489B, a 6.84% decline year-over-year.
  • Bristol Myers Squibb total assets for 2022 were $96.82B, a 11.43% decline from 2021.
  • Bristol Myers Squibb total assets for 2021 were $109.314B, a 7.74% decline from 2020.
  • Bristol Myers Squibb total assets for 2020 were $118.481B, a 8.82% decline from 2019.
  
Bristol Myers Squibb Annual Total Assets
(Millions of US $)
2022 $96,820
2021 $109,314
2020 $118,481
2019 $129,944
2018 $34,986
2017 $33,551
2016 $33,707
2015 $31,748
2014 $33,749
2013 $38,592
2012 $35,897
2011 $32,970
2010 $31,076
2009 $31,008
Bristol Myers Squibb Quarterly Total Assets
(Millions of US $)
2023-06-30 $93,489
2023-03-31 $94,281
2022-12-31 $96,820
2022-09-30 $98,196
2022-06-30 $100,357
2022-03-31 $103,034
2021-12-31 $109,314
2021-09-30 $110,893
2021-06-30 $110,797
2021-03-31 $112,435
2020-12-31 $118,481
2020-09-30 $125,536
2020-06-30 $128,076
2020-03-31 $129,285
2019-12-31 $129,944
2019-09-30 $57,433
2019-06-30 $55,163
2019-03-31 $34,834
2018-12-31 $34,986
2018-09-30 $33,734
2018-06-30 $32,641
2018-03-31 $33,083
2017-12-31 $33,551
2017-09-30 $33,977
2017-06-30 $33,409
2017-03-31 $32,937
2016-12-31 $33,707
2016-09-30 $33,727
2016-06-30 $32,831
2016-03-31 $31,892
2015-12-31 $31,748
2015-09-30 $31,779
2015-06-30 $31,954
2015-03-31 $33,579
2014-12-31 $33,749
2014-09-30 $33,450
2014-06-30 $33,503
2014-03-31 $33,424
2013-12-31 $38,592
2013-09-30 $36,804
2013-06-30 $36,252
2013-03-31 $35,958
2012-12-31 $35,897
2012-09-30 $36,044
2012-06-30 $31,667
2012-03-31 $32,408
2011-12-31 $32,970
2011-09-30 $32,014
2011-06-30 $31,833
2011-03-31 $30,851
2010-12-31 $31,076
2010-09-30 $31,885
2010-06-30 $31,051
2010-03-31 $30,753
2009-12-31 $31,008
2009-09-30 $30,951
2009-06-30 $29,809
2009-03-31 $29,693
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $122.296B $46.159B
Bristol-Myers Squibb is a one of the leading global specialty biopharmaceutical companies focused on the development of treatments targeting serious diseases like cancer, inflammatory, immunologic, cardiovascular or fibrotic diseases. Backed by its blockbuster immuno-oncology drug, Opdivo, Bristol-Myers has a strong oncology portfolio, comprising other drugs like Revlimid, Pomalyst, Sprycel, Yervoy and Empliciti. It also has important immunology and cardiovascular drugs like Orencia and Eliquis. It's experiencing growth in both the Eliquis brand and the market, while also advancing its Factor XIa inhibitor program. After the sale of the global Diabetes business to AstraZeneca and the discontinuation of discovery research efforts in virology, it's focusing solely on research in core therapeutic areas like oncology, immuno-oncology, immunoscience, cardiovascular, fibrosis and genetically defined diseases. It acquried Celgene Corporation and MyoKardia. It received regulatory approvals for Reblozyl and Inrebic.
Stock Name Country Market Cap PE Ratio
Amgen (AMGN) United States $143.910B 15.14
Gilead Sciences (GILD) United States $94.111B 12.03
Vertex Pharmaceuticals (VRTX) United States $90.769B 26.74
Regeneron Pharmaceuticals (REGN) United States $90.365B 21.81
CSL (CSLLY) Australia $78.962B 0.00
GSK (GSK) United Kingdom $76.331B 10.36
Seagen (SGEN) United States $40.573B 0.00
Biogen (BIIB) United States $37.372B 15.89
Moderna (MRNA) United States $37.344B 36.21
Argenex SE (ARGX) Netherlands $28.305B 0.00
Horizon Therapeutics Public (HZNP) Ireland $26.504B 25.78
BioNTech SE (BNTX) Germany $24.547B 5.71
Genmab (GMAB) Denmark $24.131B 36.53
Alnylam Pharmaceuticals (ALNY) United States $21.881B 0.00
Illumina (ILMN) United States $20.406B 146.49
BeiGene (BGNE) Cayman Islands $17.971B 0.00
BioMarin Pharmaceutical (BMRN) United States $16.571B 88.06
Incyte (INCY) United States $13.284B 32.39
Exact Sciences (EXAS) United States $12.002B 0.00
Bio-Rad Laboratories (BIO.B) United States $10.868B 30.51
Bio-Techne Corp (TECH) United States $10.684B 38.09
Legend Biotech (LEGN) United States $10.624B 0.00
Sarepta Therapeutics (SRPT) United States $10.508B 0.00
Verona Pharma American Depositary Share (VRNA) United Kingdom $10.482B 0.00
Roivant Sciences (ROIV) United Kingdom $9.577B 0.00
QIAGEN (QGEN) Netherlands $9.031B 19.04
Repligen (RGEN) United States $8.847B 60.56
Exelixis (EXEL) United States $6.925B 42.65
Reata Pharmaceuticals (RETA) United States $6.576B 0.00
Sino Biopharmaceutical (SBMFF) Hong Kong, SAR China $6.397B 0.00
Karuna Therapeutics (KRTX) United States $6.301B 0.00
Swedish Orphan Biovitrum (BIOVF) Sweden $5.888B 19.00
Ascendis Pharma (ASND) Denmark $5.384B 0.00
Immunovant (IMVT) United States $5.222B 0.00
Intra-Cellular Therapies (ITCI) United States $5.156B 0.00
Apellis Pharmaceuticals (APLS) United States $5.084B 0.00
Halozyme Therapeutics (HALO) United States $5.075B 17.10
Vaxcyte (PCVX) United States $4.840B 0.00
Alkermes (ALKS) Ireland $4.825B 241.42
ACADIA Pharmaceuticals (ACAD) United States $3.869B 0.00
Insmed (INSM) United States $3.706B 0.00
CRISPR Therapeutics AG (CRSP) Switzerland $3.662B 0.00
Ginkgo Bioworks Holdings (DNA) United States $3.631B 0.00
Amicus Therapeutics (FOLD) United States $3.514B 0.00
MoonLake Immunotherapeutics (MLTX) Switzerland $3.466B 0.00
Axsome Therapeutics (AXSM) United States $3.419B 0.00
Krystal Biotech (KRYS) United States $3.229B 0.00
Guardant Health (GH) United States $3.036B 0.00
Blueprint Medicines (BPMC) United States $3.029B 0.00
Denali Therapeutics (DNLI) United States $2.939B 0.00
Cytokinetics (CYTK) United States $2.880B 0.00
Intellia Therapeutics (NTLA) United States $2.863B 0.00
HUTCHMED (China) (HCM) Hong Kong, SAR China $2.824B 0.00
Ultragenyx Pharmaceutical (RARE) United States $2.675B 0.00
Prothena (PRTA) Ireland $2.547B 0.00
Akero Therapeutics (AKRO) United States $2.537B 0.00
Fortrea Holdings (FTRE) United States $2.517B 0.00
Immunocore Holdings (IMCR) United Kingdom $2.486B 0.00
Zai Lab (ZLAB) China $2.463B 0.00
Nuvalent (NUVL) United States $2.400B 0.00
Mirati Therapeutics (MRTX) United States $2.382B 0.00
Zealand Pharma (ZLDPF) Denmark $2.278B 0.00
Galapagos (GLPG) Belgium $2.270B 0.00
Xenon Pharmaceuticals (XENE) Canada $2.247B 0.00
Certara (CERT) United States $2.221B 36.58
Harmony Biosciences Holdings (HRMY) United States $2.040B 11.33
Ventyx Biosciences (VTYX) United States $1.998B 0.00
Beam Therapeutics (BEAM) United States $1.869B 0.00
Dynavax Technologies (DVAX) United States $1.834B 19.78
Bavarian Nordic (BVNRY) Denmark $1.693B 10.20
Arcellx (ACLX) United States $1.676B 0.00
Rocket Pharmaceuticals (RCKT) United States $1.656B 0.00
CureVac (CVAC) Germany $1.647B 0.00
Vericel (VCEL) United States $1.596B 0.00
NeoGenomics (NEO) United States $1.570B 0.00
IDEAYA Biosciences (IDYA) United States $1.521B 0.00
SpringWorks Therapeutics (SWTX) United States $1.489B 0.00
Zentalis Pharmaceuticals (ZNTL) United States $1.447B 0.00
Arcus Biosciences (RCUS) United States $1.430B 0.00
AbCellera Biologics (ABCL) Canada $1.360B 0.00
Rhythm Pharmaceuticals (RYTM) United States $1.353B 0.00
Myriad Genetics (MYGN) United States $1.309B 0.00
Structure Therapeutics (GPCR) United States $1.295B 0.00
Celldex Therapeutics (CLDX) United States $1.253B 0.00
Vir Biotechnology (VIR) United States $1.242B 0.00
Biohaven (BHVN) United States $1.206B 0.00
Viking Therapeutics (VKTX) United States $1.193B 0.00
ANI Pharmaceuticals (ANIP) United States $1.189B 19.02
89BIO (ETNB) United States $1.184B 0.00
Kiniksa Pharmaceuticals (KNSA) Bermuda $1.170B 31.47
Mirum Pharmaceuticals (MIRM) United States $1.163B 0.00
Twist Bioscience (TWST) United States $1.140B 0.00
Merus (MRUS) Netherlands $1.135B 0.00
Geron (GERN) United States $1.130B 0.00
Tango Therapeutics (TNGX) United States $1.126B 0.00
Arvinas (ARVN) United States $1.116B 0.00
Disc Medicine (IRON) United States $1.108B 0.00
Iovance Biotherapeutics (IOVA) United States $1.100B 0.00
Syndax Pharmaceuticals (SNDX) United States $1.095B 0.00
Revance Therapeutics (RVNC) United States $1.092B 0.00
Day One Biopharmaceuticals (DAWN) United States $1.086B 0.00
MannKind (MNKD) United States $1.081B 0.00
Northwest Biotherapeutics (NWBO) United States $1.074B 0.00
Apogee Therapeutics (APGE) United States $1.054B 0.00
Ligand Pharmaceuticals (LGND) United States $1.045B 23.16
Morphic Holding (MORF) United States $1.022B 0.00
Protagonist Therapeutics (PTGX) United States $1.006B 0.00
Pliant Therapeutics (PLRX) United States $0.997B 0.00
Prime Medicine (PRME) United States $0.997B 0.00
Deciphera Pharmaceuticals (DCPH) United States $0.982B 0.00
Keros Therapeutics (KROS) United States $0.953B 0.00
Replimune (REPL) United States $0.942B 0.00
Pharming Group (PHGUF) Netherlands $0.913B 0.00
ACELYRIN, INC (SLRN) United States $0.908B 0.00
MiMedx (MDXG) United States $0.903B 0.00
Pharming Group (PHAR) Netherlands $0.876B 0.00
Inhibrx (INBX) United States $0.867B 0.00
Cytek Biosciences (CTKB) United States $0.865B 0.00
Immatics (IMTX) Germany $0.856B 0.00
Belite Bio (BLTE) United States $0.851B 0.00
Kymera Therapeutics (KYMR) United States $0.849B 0.00
Cogent Biosciences (COGT) United States $0.828B 0.00
Adaptive Biotechnologies (ADPT) United States $0.804B 0.00
ADMA Biologics Inc (ADMA) United States $0.798B 0.00
Intercept Pharmaceuticals (ICPT) United States $0.782B 0.00
PureTech Health (PRTC) United States $0.778B 0.00
Adaptimmune Therapeutics (ADAP) United Kingdom $0.756B 0.00
REGENXBIO (RGNX) United States $0.755B 0.00
Sana Biotechnology (SANA) United States $0.742B 0.00
POINT Biopharma Global (PNT) United States $0.721B 7.84
Arcturus Therapeutics Holdings (ARCT) United States $0.711B 14.07
Vera Therapeutics (VERA) United States $0.702B 0.00
Viridian Therapeutics (VRDN) United States $0.678B 0.00
Novavax (NVAX) United States $0.671B 0.00
ImmunityBio (IBRX) United States $0.671B 0.00
Ambrx Biopharma (AMAM) United States $0.657B 0.00
HilleVax (HLVX) United States $0.656B 0.00
Sinovac Biotech (SVA) China $0.644B 0.00
Travere Therapeutics (TVTX) United States $0.640B 0.00
Avid Bioservices (CDMO) United States $0.632B 0.00
Kura Oncology (KURA) United States $0.627B 0.00
Pharma Mar (PHMMF) Spain $0.621B 0.00
Bicycle Therapeutics (BCYC) United Kingdom $0.598B 0.00
Basilea Pharmaceutica AG (BPMUF) Switzerland $0.593B 0.00
Cabaletta Bio (CABA) United States $0.592B 0.00
Phathom Pharmaceuticals (PHAT) United States $0.583B 0.00
Tyra Biosciences (TYRA) United States $0.579B 0.00
Editas Medicine (EDIT) United States $0.576B 0.00
Rapt Therapeutics (RAPT) United States $0.574B 0.00
Allogene Therapeutics (ALLO) United States $0.563B 0.00
Anavex Life Sciences (AVXL) United States $0.557B 0.00
Genelux (GNLX) United States $0.554B 0.00
Alector (ALEC) United States $0.539B 0.00
Olema Pharmaceuticals (OLMA) United States $0.532B 0.00
Tarsus Pharmaceuticals (TARS) United States $0.529B 0.00
Repare Therapeutics (RPTX) Canada $0.524B 0.00
WAVE Life Sciences (WVE) Singapore $0.524B 0.00
Biomea Fusion (BMEA) United States $0.499B 0.00
Entrada Therapeutics (TRDA) United States $0.494B 0.00
AnaptysBio (ANAB) United States $0.482B 0.00
Avidity Biosciences (RNA) United States $0.473B 0.00
Janux Therapeutics (JANX) United States $0.458B 0.00
23andMe Holding (ME) United States $0.455B 0.00
IGM Biosciences (IGMS) United States $0.451B 0.00
Agenus (AGEN) United States $0.437B 0.00
Caribou Biosciences (CRBU) United States $0.433B 0.00
Zymeworks (ZYME) United States $0.432B 2.28
Castle Biosciences (CSTL) United States $0.431B 0.00
Cullinan Oncology (CGEM) United States $0.428B 0.00
Mineralys Therapeutics (MLYS) United States $0.413B 0.00
Nurix Therapeutics (NRIX) United States $0.411B 0.00
Icosavax (ICVX) United States $0.410B 0.00
Liquidia Technologies (LQDA) United States $0.409B 0.00
ITeos Therapeutics (ITOS) United States $0.406B 0.00
Autolus Therapeutics (AUTL) United Kingdom $0.406B 0.00
Oculis Holding AG (OCS) Switzerland $0.402B 0.00
Nautilus Biotechnology (NAUT) United States $0.397B 0.00
Edgewise Therapeutics (EWTX) United States $0.388B 0.00
Oric Pharmaceuticals (ORIC) United States $0.384B 0.00
Scholar Rock Holding (SRRK) United States $0.382B 0.00
Coherus BioSciences (CHRS) United States $0.376B 0.00
Aerovate Therapeutics (AVTE) United States $0.362B 0.00
Urogen Pharma (URGN) United States $0.362B 0.00
Arcutis Biotherapeutics (ARQT) United States $0.359B 0.00
Precigen (PGEN) United States $0.358B 0.00
Aura Biosciences (AURA) United States $0.355B 0.00
Amarin (AMRN) Ireland $0.341B 0.00
Voyager Therapeutics (VYGR) United States $0.337B 3.38
Oxford BioMedica (OXBDF) United Kingdom $0.336B 0.00
AN2 Therapeutics (ANTX) United States $0.334B 0.00
Apollomics (APLM) Taiwan $0.331B 0.00
UniQure (QURE) Netherlands $0.331B 0.00
Bluebird Bio (BLUE) United States $0.329B 0.00
Arbutus Biopharma (ABUS) United States $0.325B 0.00
Erasca (ERAS) United States $0.320B 0.00
Monte Rosa Therapeutics (GLUE) United States $0.317B 0.00
Terns Pharmaceuticals (TERN) United States $0.313B 0.00
MaxCyte (MXCT) United States $0.313B 0.00
MeiraGTx Holdings (MGTX) United States $0.308B 0.00
Nuvation Bio (NUVB) United States $0.304B 0.00
Seres Therapeutics (MCRB) United States $0.299B 0.00
Humacyte (HUMA) United States $0.294B 0.00
Lexicon Pharmaceuticals (LXRX) United States $0.287B 0.00
Zura Bio (ZURA) United States $0.284B 0.00
Orchestra BioMed Holdings (OBIO) United States $0.282B 0.00
EYEPOINT PHARMACEUTICALS, INC (EYPT) United States $0.280B 0.00
Inozyme Pharma (INZY) United States $0.277B 0.00
Fulcrum Therapeutics (FULC) United States $0.273B 0.00
Anika Therapeutics (ANIK) United States $0.271B 0.00
Ovid Therapeutics (OVID) United States $0.268B 0.00
Vanda Pharmaceuticals (VNDA) United States $0.261B 16.82
ScPharmaceuticals (SCPH) United States $0.255B 0.00
Compass Therapeutics (CMPX) United States $0.254B 0.00
Atea Pharmaceuticals (AVIR) United States $0.254B 0.00
Third Harmonic Bio (THRD) United States $0.252B 0.00
AC Immune (ACIU) Switzerland $0.251B 0.00
DBV Technologies S.A (DBVT) France $0.250B 0.00
Acumen Pharmaceuticals (ABOS) United States $0.248B 0.00
Lifecore Biomedical (LFCR) United States $0.240B 0.00
Nuvectis Pharma (NVCT) United States $0.236B 0.00
Astria Therapeutics (ATXS) United States $0.235B 0.00
Y-mAbs Therapeutics (YMAB) United States $0.233B 0.00
Scilex Holding (SCLX) United States $0.233B 0.00
Inventiva S.A (IVA) France $0.230B 0.00
Kamada (KMDA) Israel $0.226B 17.41
Verastem (VSTM) United States $0.226B 0.00
Immuneering (IMRX) United States $0.225B 0.00
Renovaro Biosciences (RENB) United States $0.221B 0.00
Akoya Biosciences (AKYA) United States $0.218B 0.00
Vigil Neuroscience (VIGL) United States $0.218B 0.00
Gracell Biotechnologies (GRCL) China $0.214B 0.00
Celcuity (CELC) United States $0.213B 0.00
Poseida Therapeutics (PSTX) United States $0.206B 0.00
ALX Oncology Holdings (ALXO) United States $0.203B 0.00
CorMedix Inc (CRMD) United States $0.201B 0.00
Innate Pharma S.A (IPHA) France $0.200B 0.00
Mesoblast (MESO) Australia $0.200B 0.00
Fate Therapeutics (FATE) United States $0.199B 0.00
Sutro Biopharma (STRO) United States $0.199B 0.00
Sagimet Biosciences (SGMT) United States $0.195B 0.00
TELA Bio (TELA) United States $0.195B 0.00
Tenaya Therapeutics (TNYA) United States $0.195B 0.00
Praxis Precision Medicines (PRAX) United States $0.190B 0.00
Allakos (ALLK) United States $0.188B 0.00
Rallybio (RLYB) United States $0.187B 0.00
Ikena Oncology (IKNA) United States $0.187B 0.00
Invivyd (IVVD) United States $0.180B 0.00
Merrimack Pharmaceuticals (MACK) United States $0.177B 0.00
Gossamer Bio (GOSS) United States $0.177B 0.00
X4 Pharmaceuticals (XFOR) United States $0.174B 0.00
2seventy Bio (TSVT) United States $0.174B 0.00
Adverum Biotechnologies (ADVM) United States $0.174B 0.00
Orchard Therapeutics (ORTX) United Kingdom $0.174B 0.00
Stoke Therapeutics (STOK) United States $0.172B 0.00
Prima BioMed (IMMP) Australia $0.171B 0.00
Vaxxinity (VAXX) United States $0.171B 0.00
Selecta Biosciences (SELB) United States $0.170B 0.00
Emergent Biosolutions (EBS) United States $0.169B 0.00
MEREO BIOPHARMA (MREO) United Kingdom $0.166B 0.00
XOMA (XOMA) United States $0.163B 0.00
GENFIT S.A (GNFT) France $0.163B 0.00
Molecular Partners AG (MOLN) Switzerland $0.163B 0.00
Oncolytics Biotech (ONCY) Canada $0.161B 0.00
PDS Biotechnology (PDSB) United States $0.161B 0.00
LianBio (LIAN) United States $0.161B 0.00
Atara Biotherapeutics (ATRA) United States $0.159B 0.00
Applied Therapeutics (APLT) United States $0.155B 0.00
Mersana Therapeutics (MRSN) United States $0.151B 0.00
Rani Therapeutics Holdings (RANI) United States $0.146B 0.00
Vor Biopharma (VOR) $0.145B 0.00
Graphite Bio (GRPH) United States $0.144B 0.00
Mind Medicine (MindMed) (MNMD) United States $0.144B 0.00
Seer (SEER) United States $0.143B 0.00
Ocean Biomedical (OCEA) United States $0.142B 0.00
Trevi Therapeutics (TRVI) United States $0.139B 0.00
Design Therapeutics (DSGN) United States $0.135B 0.00
Adocia (ADOCY) France $0.135B 0.00
Annexon (ANNX) United States $0.130B 0.00
InflaRx (IFRX) Germany $0.130B 0.00
Puma Biotechnology (PBYI) United States $0.129B 0.00
TScan Therapeutics (TCRX) United States $0.129B 0.00
Longboard Pharmaceuticals (LBPH) United States $0.129B 0.00
Aadi Bioscience (AADI) United States $0.128B 0.00
Omega Therapeutics (OMGA) United States $0.127B 0.00
XBiotech (XBIT) United States $0.127B 0.00
INmune Bio (INMB) United States $0.126B 0.00
Sangamo Therapeutics (SGMO) United States $0.120B 0.00
PepGen (PEPG) United States $0.120B 0.00
Absci (ABSI) United States $0.119B 0.00
Theseus Pharmaceuticals (THRX) United States $0.119B 0.00
Eton Pharmaceuticals (ETON) United States $0.119B 0.00
ProQR Therapeutics (PRQR) Netherlands $0.117B 0.00
Gritstone Bio (GRTS) United States $0.112B 0.00
Greenwich LifeSciences (GLSI) United States $0.110B 0.00
ChromaDex (CDXC) United States $0.107B 0.00
Kodiak Sciences (KOD) United States $0.107B 0.00
Vaccitech (VACC) United Kingdom $0.106B 0.00
Cue Biopharma (CUE) United States $0.106B 0.00
Codexis (CDXS) United States $0.105B 0.00
Ocugen (OCGN) United States $0.104B 0.00
MediciNova (MNOV) United States $0.103B 0.00
I-Mab (IMAB) China $0.102B 0.00
Gamida Cell (GMDA) United States $0.102B 0.00
Opthea (OPT) Australia $0.102B 0.00
ANIXA BIOSCIENCES INC (ANIX) United States $0.101B 0.00
Inovio Pharmaceuticals (INO) United States $0.101B 0.00
Bionano Genomics (BNGO) United States $0.100B 0.00
Milestone Pharmaceuticals (MIST) Canada $0.100B 0.00
Abeona Therapeutics (ABEO) United States $0.100B 0.00
DiaMedica Therapeutics (DMAC) United States $0.099B 0.00
PhenomeX (CELL) United States $0.099B 0.00
Genenta Science S.p.A (GNTA) Italy $0.098B 0.00
Cara Therapeutics (CARA) United States $0.097B 0.00
C4 Therapeutics (CCCC) United States $0.092B 0.00
Spruce Biosciences (SPRB) United States $0.092B 0.00
ATyr Pharma (LIFE) United States $0.091B 0.00
Cellectis S.A (CLLS) France $0.090B 0.00
Immunome (IMNM) United States $0.090B 0.00
BRIACELL THERAP (BCTX) Canada $0.089B 0.00
Cidara Therapeutics (CDTX) United States $0.088B 0.00
NGM Biopharmaceuticals (NGM) United States $0.087B 0.00
Annovis Bio (ANVS) United States $0.086B 0.00
IO Biotech (IOBT) Denmark $0.085B 0.00
Data Knights Acquisition (DKDCA) United Kingdom $0.085B 0.00
Ocuphire Pharma (OCUP) United States $0.084B 4.79
CytomX Therapeutics (CTMX) United States $0.084B 0.00
BioAtla (BCAB) United States $0.084B 0.00
Compugen (CGEN) Israel $0.083B 0.00
Alpha Teknova (TKNO) United States $0.083B 0.00
Nkarta (NKTX) United States $0.082B 0.00
Turnstone Biologics (TSBX) United States $0.081B 0.00
Syros Pharmaceuticals (SYRS) United States $0.081B 0.00
BioXcel Therapeutics (BTAI) United States $0.081B 0.00
Beyond Air (XAIR) United States $0.080B 0.00
Graf Acquisition IV (GFOR) United States $0.079B 0.00
Anebulo Pharmaceuticals (ANEB) United States $0.079B 0.00
Kezar Life Sciences (KZR) United States $0.079B 0.00
Evelo Biosciences (EVLO) United States $0.076B 0.00
Jasper Therapeutics (JSPR) United States $0.075B 0.00
Athira Pharma (ATHA) United States $0.075B 0.00
Elicio Therapeutics (ELTX) United States $0.074B 0.00
HCW Biologics (HCWB) United States $0.074B 0.00
Kronos Bio (KRON) United States $0.073B 0.00
Cardiff Oncology (CRDF) United States $0.072B 0.00
Corvus Pharmaceuticals (CRVS) United States $0.072B 0.00
Werewolf Therapeutics (HOWL) United States $0.071B 0.00
Genetron Holdings (GTH) China $0.071B 0.00
ADC Therapeutics SA (ADCT) Switzerland $0.070B 0.00
AVROBIO (AVRO) United States $0.069B 0.00
Affimed (AFMD) Germany $0.069B 0.00
Enzo Biochem (ENZ) United States $0.069B 0.00
Tiziana Life Sciences (TLSA) United Kingdom $0.068B 0.00
Clene (CLNN) United States $0.067B 0.00
G1 Therapeutics (GTHX) United States $0.065B 0.00
Kinnate Biopharma (KNTE) United States $0.065B 0.00
Immix Biopharma (IMMX) United States $0.064B 0.00
Spero Therapeutics (SPRO) United States $0.064B 0.00
Shattuck Labs (STTK) United States $0.064B 0.00
Eyenovia (EYEN) United States $0.063B 0.00
Prenetics Global (PRE) Cayman Islands $0.062B 1.45
Adicet Bio (ACET) United States $0.062B 0.00
Xilio Therapeutics (XLO) United States $0.061B 0.00
Adagene (ADAG) China $0.060B 0.00
Immunic (IMUX) United States $0.060B 0.00
Oncobiologics (OTLK) United States $0.057B 0.00
Sorrento Therapeutics (SRNEQ) United States $0.056B 0.00
Dyadic (DYAI) United States $0.055B 0.00
Instil Bio (TIL) United States $0.053B 0.00
Clearside Biomedical (CLSD) United States $0.053B 0.00
Intensity Therapeutics (INTS) United States $0.053B 0.00
Solid Biosciences (SLDB) United States $0.052B 0.00
VistaGen Therapeutics (VTGN) United States $0.050B 0.00
Dianthus Therapeutics (DNTH) United States $0.050B 0.00
HOOKIPA Pharma (HOOK) United States $0.050B 0.00
Curis (CRIS) United States $0.050B 0.00
Rezolute (RZLT) United States $0.050B 0.00
Galena Biopharma (SLS) United States $0.048B 0.00
OKYO Pharma (OKYO) $0.048B 0.00
VTv Therapeutics (VTVT) United States $0.047B 0.00
Longeveron (LGVN) United States $0.047B 0.00
Science 37 Holdings (SNCE) United States $0.047B 0.00
Celularity (CELU) United States $0.046B 0.00
Aeglea BioTherapeutics (AGLE) United States $0.046B 0.00
MiNK Therapeutics (INKT) United States $0.043B 0.00
Precision BioSciences (DTIL) United States $0.043B 0.00
Quince Therapeutics (QNCX) United States $0.043B 0.00
Theratechnologies (THTX) Canada $0.042B 0.00
Dare Bioscience (DARE) United States $0.041B 0.00
CytoMed Therapeutics (GDTC) Singapore $0.040B 0.00
Connect Biopharma Holdings (CNTB) United States $0.040B 0.00
Coya Therapeutics (COYA) United States $0.040B 0.00
Portage Biotech (PRTG) $0.040B 0.00
Lantern Pharma (LTRN) United States $0.039B 0.00
Cognition Therapeutics (CGTX) United States $0.039B 0.00
Mainz Biomed (MYNZ) Germany $0.038B 0.00
Fortress Biotech (FBIO) United States $0.038B 0.00
Passage Bio (PASG) United States $0.037B 0.00
NextCure (NXTC) United States $0.037B 0.00
Bolt Biotherapeutics (BOLT) United States $0.037B 0.00
IN8bio (INAB) United States $0.036B 0.00
Miromatrix Medical (MIRO) United States $0.036B 0.00
Achilles Therapeutics (ACHL) United Kingdom $0.036B 0.00
Leap Therapeutics (LPTX) United States $0.035B 0.00
UNITY Biotechnology (UBX) United States $0.035B 0.00
Neoleukin Therapeutics (NLTX) United States $0.034B 0.00
Telesis Bio (TBIO) United States $0.034B 0.00
ASLAN Pharmaceuticals (ASLN) Singapore $0.032B 0.00
Aligos Therapeutics (ALGS) United States $0.032B 0.00
Rain Oncology (RAIN) United States $0.031B 0.00
Biora Therapeutics (BIOR) United States $0.031B 0.00
Pieris Pharmaceuticals (PIRS) United States $0.030B 0.00
NuCana (NCNA) United Kingdom $0.030B 0.00
BeyondSpring (BYSI) United States $0.030B 0.00
Checkpoint Therapeutics (CKPT) United States $0.030B 0.00
Eledon Pharmaceuticals (ELDN) United States $0.029B 0.00
Elevation Oncology (ELEV) United States $0.029B 0.00
Candel Therapeutics (CADL) United States $0.029B 0.00
Alimera Sciences (ALIM) United States $0.028B 0.00
Cyclo Therapeutics (CYTH) United States $0.028B 0.00
SAB Biotherapeutics (SABS) United States $0.027B 0.00
Liminal BioSciences (LMNL) Canada $0.026B 0.00
TradeUP Acquisition (UPTD) United States $0.026B 0.00
Evogene (EVGN) Israel $0.025B 0.00
Forte Biosciences (FBRX) United States $0.025B 0.00
Equillium (EQ) United States $0.025B 0.00
Coeptis Therapeutics Holdings (COEP) United States $0.024B 0.00
KALA BIO (KALA) United States $0.024B 0.00
Kineta (KA) United States $0.024B 0.00
Pluri (PLUR) Israel $0.024B 0.00
GENPREX (GNPX) United States $0.024B 0.00
Axcella Health (AXLA) United States $0.023B 0.00
Sensei Biotherapeutics (SNSE) United States $0.023B 0.00
Seelos Therapeutics (SEEL) United States $0.023B 0.00
Synlogic (SYBX) United States $0.023B 0.00
Femasys (FEMY) United States $0.022B 0.00
Lumos Pharma (LUMO) United States $0.022B 0.00
EFFECTOR Therapeutics (EFTR) United States $0.022B 0.00
Evaxion Biotech (EVAX) Denmark $0.022B 0.00
Cocrystal Pharma (COCP) United States $0.022B 0.00
Aptose Biosciences (APTO) Canada $0.021B 0.00
Senti Biosciences (SNTI) United States $0.021B 0.00
YS Biopharma (YS) China $0.021B 1.04
Medicenna Therapeutics (MDNA) Canada $0.021B 0.00
Elutia (ELUT) United States $0.020B 0.00
Entera Bio (ENTX) Israel $0.020B 0.00
Vincerx Pharma (VINC) United States $0.020B 0.00
Acurx Pharmaceuticals (ACXP) United States $0.020B 0.00
Purple Biotech (PPBT) Israel $0.019B 0.00
Catalyst Biosciences (CBIO) United States $0.019B 0.00
Acorda Therapeutics (ACOR) United States $0.019B 0.00
Mustang Bio (MBIO) United States $0.019B 0.00
Alzamend Neuro (ALZN) United States $0.019B 0.00
Hepion Pharmaceuticals (HEPA) United States $0.019B 0.00
Virios Therapeutics (VIRI) United States $0.018B 0.00
Brainstorm Cell Therapeutics (BCLI) United States $0.018B 0.00
Edesa Biotech (EDSA) Canada $0.017B 0.00
Orgenesis (ORGS) United States $0.017B 0.00
AquaBounty Technologies (AQB) United States $0.017B 0.00
Freeline Therapeutics Holdings (FRLN) United Kingdom $0.017B 0.00
Lisata Therapeutics (LSTA) United States $0.017B 0.00
Promis Neurosciences (PMN) Canada $0.017B 0.00
Vascular Biogenics (VBLT) Israel $0.017B 0.00
Novogen (KZIA) Australia $0.016B 0.00
Genetic Technologies (GENE) Australia $0.016B 0.00
PHAXIAM Therapeutics S.A (PHXM) France $0.016B 0.00
Aprea Therapeutics (APRE) United States $0.016B 0.00
Galecto (GLTO) Denmark $0.015B 0.00
CalciMedica (CALC) United States $0.015B 0.00
Akari Therapeutics (AKTX) United Kingdom $0.015B 0.00
Eiger BioPharmaceuticals (EIGR) United States $0.015B 0.00
RenovoRx (RNXT) United States $0.015B 0.00
VBI Vaccines (VBIV) United States $0.014B 0.00
Frequency Therapeutics (FREQ) United States $0.014B 0.00
Senesco Technologies (ELOX) United States $0.014B 0.00
GeoVax Labs (GOVX) United States $0.014B 0.00
NeuroBo Pharmaceuticals (NRBO) United States $0.013B 0.00
Moleculin Biotech (MBRX) United States $0.013B 0.00
Biofrontera (BFRI) United States $0.012B 0.00
ZIVO Bioscience (ZIVO) United States $0.012B 0.00
Pasithea Therapeutics (KTTA) United States $0.012B 0.00
TFF Pharmaceuticals (TFFP) United States $0.012B 0.00
AEterna Zentaris (AEZS) Canada $0.012B 0.00
Landos Biopharma (LABP) United States $0.012B 0.00
Organovo Holdings (ONVO) United States $0.012B 0.00
IMMURON (IMRN) Australia $0.011B 0.00
Eterna Therapeutics (ERNA) United States $0.011B 0.00
Cingulate (CING) United States $0.011B 0.00
Talis Biomedical (TLIS) United States $0.011B 0.00
Comera Life Sciences Holdings (CMRA) United States $0.011B 0.00
Prana Biotechnology (ATHE) Australia $0.011B 0.00
GT Biopharma (GTBP) United States $0.010B 0.00
Chemomab Therapeutics (CMMB) Israel $0.010B 0.00
Atreca (BCEL) United States $0.010B 0.00
BioAffinity Technologies (BIAF) United States $0.010B 0.00
Avalon GloboCare (ALBT) United States $0.010B 0.00
ARAVIVE, INC (ARAV) United States $0.010B 0.00
Imunon (IMNN) United States $0.010B 0.00
Lipella Pharmaceuticals (LIPO) United States $0.010B 0.00
Blue Water Biotech (BWV) United States $0.009B 0.00
Virpax Pharmaceuticals (VRPX) United States $0.009B 0.00
BioCardia (BCDA) United States $0.009B 0.00
Cyclerion Therapeutics (CYCN) United States $0.009B 0.00
Trevena (TRVN) United States $0.009B 0.00
Cadrenal Therapeutics (CVKD) United States $0.009B 0.00
Cohbar (CWBR) United States $0.008B 0.00
NeuroSense Therapeutics (NRSN) Israel $0.008B 0.00
Monopar Therapeutics (MNPR) United States $0.008B 0.00
Galera Therapeutics (GRTX) United States $0.008B 0.00
Sunshine Biopharma (SBFM) Canada $0.008B 0.00
Atrinsic (PTIX) United States $0.008B 0.00
Bionomics (BNOX) Australia $0.008B 0.00
Lexaria Bioscience (LEXX) Canada $0.008B 0.00
Creative Medical Technology Holdings (CELZ) United States $0.008B 0.00
Titan Pharmaceuticals (TTNP) United States $0.008B 0.00
Athersys (ATHX) United States $0.007B 0.00
Pulmatrix (PULM) United States $0.007B 0.00
Biodexa Pharmaceuticals (BDRX) United Kingdom $0.007B 0.00
Biorestorative Therapies (BRTX) United States $0.007B 0.00
Kintara Therapeutics (KTRA) United States $0.007B 0.00
Tenax Therapeutics (TENX) United States $0.007B 0.00
Applied Molecular Transport (AMTI) United States $0.007B 0.00
Biophytis SA (BPTS) France $0.007B 0.00
Aileron Therapeutics (ALRN) United States $0.007B 0.00
Exicure (XCUR) United States $0.007B 0.46
CervoMed (CRVO) United States $0.006B 0.00
Aytu BioPharma (AYTU) United States $0.006B 0.00
Bright Minds Biosciences (DRUG) United States $0.006B 0.00
TRACON Pharmaceuticals (TCON) United States $0.006B 0.00
Silo Pharma (SILO) United States $0.006B 0.00
Vaccinex (VCNX) United States $0.006B 0.00
NexImmune (NEXI) United States $0.005B 0.00
PaxMedica (PXMD) United States $0.005B 0.00
Benitec Biopharma (BNTC) United States $0.005B 0.00
Sonnet BioTherapeutics Holdings (SONN) United States $0.005B 0.00
Hoth Therapeutics (HOTH) United States $0.005B 0.00
Virax Biolabs Group (VRAX) United Kingdom $0.005B 0.00
GRI Bio (GRI) United States $0.005B 0.00
Bellerophon Therapeutics (BLPH) United States $0.005B 0.00
Cardio Diagnostics Holdings (CDIO) United States $0.005B 0.00
Enveric Biosciences (ENVB) United States $0.005B 0.00
Windtree Therapeutics (WINT) United States $0.005B 0.00
CNS Pharmaceuticals (CNSP) United States $0.005B 0.00
Lixte Biotechnology Holdings (LIXT) United States $0.004B 0.00
Artelo Biosciences (ARTL) United States $0.004B 0.00
Soligenix (SNGX) United States $0.004B 0.00
Revelation Biosciences (REVB) United States $0.004B 0.00
Ensysce Biosciences (ENSC) United States $0.004B 0.00
ZyVersa Therapeutics (ZVSA) United States $0.004B 0.00
Cyclacel Pharmaceuticals (CYCC) United States $0.004B 0.00
Synaptogenix (SNPX) United States $0.004B 0.00
Adial Pharmaceuticals (ADIL) United States $0.004B 0.00
Panbela Therapeutics (PBLA) United States $0.004B 0.00
ABVC BioPharma (ABVC) United States $0.004B 0.00
Palisade Bio (PALI) United States $0.004B 0.04
Aptevo Therapeutics (APVO) United States $0.004B 0.00
Dermata Therapeutics (DRMA) United States $0.003B 0.00
ThermoGenesis Holdings (THMO) United States $0.003B 0.00
Aceragen (ACGN) United States $0.003B 0.00
180 Life Sciences (ATNF) United States $0.003B 0.25
Bone Biologics (BBLG) United States $0.002B 0.00
First Wave BioPharma (FWBI) United States $0.002B 0.06
Invo BioScience (INVO) United States $0.002B 0.00
Allarity Therapeutics (ALLR) United States $0.002B 0.00
NeuBase Therapeutics (NBSE) United States $0.002B 0.00
Scinai Immunotherapeutics (SCNI) Israel $0.002B 0.00
TC BioPharm (Holdings) (TCBP) United Kingdom $0.000B 0.00
MorphoSys AG (MOR) Germany $0.000B 16.88
Regencell Bioscience Holdings (RGC) Hong Kong, SAR China $0.000B 0.00
ARCA Biopharma (ABIO) United States $0.000B 0.00
Alvotech (ALVO) $0.000B 0.00
CollPlant Biotechnologies (CLGN) Israel $0.000B 0.00
Celyad SA (CYAD) Belgium $0.000B 0.00
GH Research (GHRS) Ireland $0.000B 0.00
LAVA Therapeutics (LVTX) Netherlands $0.000B 0.00
Motif Bio Plc (MTFB) United Kingdom $0.000B 0.00
PDL BioPharma (PDLI) United States $0.000B 0.00
Pharvaris (PHVS) Netherlands $0.000B 0.00
VectivBio Holding AG (VECT) Switzerland $0.000B 0.00